精確射線 ARAY 深 滬
已收盤 07-02 16:00:00 美东时间
0.2549
-0.005
-1.77%
華盛通- 最 高0.2849
- 今 開0.255
- 成交量 229.80万股
- 最 低 0.253
- 昨 收 0.2595
- 總市值 3032.38万
- 52周最高 2.10
- 市盈率 靜 --
- 換手率 1.93%
- 52周最低 0.2475
- 委 比 -99.97%
- 總股本 1.19亿
- 歷史最高 10.85
- 量 比 0.57
- 振 幅 12.29%
- 歷史最低 0.2475
- 每 手 1
- 風險率 0.49%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Accuray Retires 2026 Convertible Notes, Simplifies Capital Structure
An announcement from Accuray ( ($ARAY) ) is now available. On June 1, 2026, Acc...
06-05 05:23
Accuray Incorporated Reports Inducement Award Under NASDAQ Listing Rules
MADISON, Wis., May 29, 2026 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported, as required by NASDAQ Listing Rules, equity inducement awards to Paul Miele, the company's new...
05-30 04:10
Accuray Earnings Call Balances Turnaround Gains, Risks
Accuray Incorporated (($ARAY)) has held its Q3 earnings call. Read on for the m...
05-20 08:27
Celanese, Accuray, Autodesk, Under Armour, Zebra Trending
Analysts are intrested in these 5 stocks: ( ($CE) ), ( ($ARAY) ), ( ($ADSK) ), ...
05-16 17:00
Accuray And The University of Wisconsin School of Medicine and Public Health Announce A New 10-Year Strategic Collaboration To Advance Personalized Cancer Treatments Using Accuray's Stellar Adaptive Radiation Therapy Platform
Accuray Incorporated (NASDAQ:ARAY) and the University of Wisconsin School of Medicine and Public Health (UW SMPH) announced a new 10‑year strategic collaboration to advance personalized cancer treatments using Accuray's
05-16 04:24
美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
Jefferies Downgrades Accuray to Hold, Lowers Price Target to $0.35
Jefferies analyst Young Li downgrades Accuray (NASDAQ:ARAY) from Buy to Hold and lowers the price target from $3.5 to $0.35.
05-13 05:33
U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis
U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis May 12 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Accuray, Aevex and Zoetis on Tuesday. HIGHLIGHTS * Accuray Inc ARAY.O : Jefferies cuts to hold from buy; cuts PT to $0.3
05-12 15:21
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Agilon Health (NYSE:AGL) shares moved upwards by 115.7% to $60.08 duri...
05-08 01:05
BTIG Downgrades Accuray to Neutral
BTIG analyst Marie Thibault downgrades Accuray (NASDAQ:ARAY) from Buy to Neutral.
05-07 18:51
